Intracardiac Echocardiography and Intravascular Ultrasound

Global Intracardiac Echocardiography and Intravascular Ultrasound Market to Reach US$1.2 Billion by 2030

The global market for Intracardiac Echocardiography and Intravascular Ultrasound estimated at US$909.8 Million in the year 2024, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Electrophysiology Procedures, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$545.2 Million by the end of the analysis period. Growth in the Left Atrial Appendage Closure segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$247.9 Million While China is Forecast to Grow at 7.7% CAGR

The Intracardiac Echocardiography and Intravascular Ultrasound market in the U.S. is estimated at US$247.9 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$237.8 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Intracardiac Echocardiography and Intravascular Ultrasound Market – Key Trends & Drivers Summarized

What Are Intracardiac Echocardiography and Intravascular Ultrasound, and Why Are They Transforming Cardiovascular Imaging?
Intracardiac echocardiography (ICE) and intravascular ultrasound (IVUS) are advanced catheter-based imaging technologies used to visualize the interior structures of the heart and blood vessels in real-time. ICE involves inserting an ultrasound catheter into the heart via a peripheral vein to produce high-resolution, near-field images of cardiac anatomy—especially useful during electrophysiology (EP) procedures, left atrial appendage closure, and transcatheter valve interventions. IVUS, on the other hand, uses a miniature ultrasound probe mounted on a catheter to visualize the inside of blood vessels, particularly coronary arteries, enabling detailed assessment of plaque composition, vessel size, and stent placement.

Both technologies offer critical advantages over traditional imaging techniques like fluoroscopy or transthoracic echocardiography (TTE). They provide real-time, cross-sectional images with greater anatomical detail, enabling precision in diagnosis, procedural planning, and therapeutic guidance. Their increasing integration into interventional cardiology, structural heart disease treatment, and vascular surgery is helping reduce complications, optimize outcomes, and minimize radiation exposure for both patients and healthcare providers.

What Innovations Are Advancing the Capabilities of ICE and IVUS Technologies?
The ICE and IVUS markets are being shaped by continual innovation in imaging resolution, catheter flexibility, integration with navigation systems, and data analytics. For ICE, the development of phased-array and rotational ICE catheters has significantly improved image quality and field of view, allowing detailed visualization of cardiac chambers, valves, and device placement. New-generation ICE catheters are now equipped with 4D and color Doppler imaging, enabling real-time flow dynamics assessment and structural guidance without needing general anesthesia or transesophageal echocardiography (TEE).

In IVUS, high-frequency catheters (up to 60 MHz) deliver ultra-high-resolution images that allow for better differentiation between fibrous, calcific, and lipid-rich plaques. Integration of IVUS with automated pullback systems, virtual histology, and AI-powered plaque characterization tools is helping clinicians make data-driven decisions during stent sizing and post-procedural evaluation. Additionally, IVUS is being increasingly used in combination with other intravascular imaging techniques like optical coherence tomography (OCT) to offer a more comprehensive understanding of coronary pathology.

Both ICE and IVUS are also benefiting from integration with advanced mapping systems, robotic-assisted platforms, and hybrid OR setups. These integrations improve spatial orientation, reduce fluoroscopy time, and enhance procedural workflow efficiency. Wireless and steerable catheter prototypes are in development, which aim to reduce setup time and improve maneuverability, particularly in complex anatomies.

Which Clinical Applications Are Driving the Adoption of ICE and IVUS Globally?
ICE and IVUS are becoming indispensable in several high-growth areas of cardiovascular intervention. In electrophysiology (EP), ICE is widely used during atrial fibrillation ablation, transseptal puncture, and device closure procedures to improve anatomical visualization and procedural safety. The increasing volume of structural heart procedures, including transcatheter aortic valve replacement (TAVR), mitral valve repair, and left atrial appendage occlusion, is further boosting ICE adoption, especially in patients for whom TEE is contraindicated.

IVUS plays a critical role in percutaneous coronary interventions (PCI), particularly in complex cases involving bifurcations, left main disease, and stent failure. It aids in lesion assessment, stent optimization, and long-term patency monitoring, reducing restenosis rates and adverse outcomes. IVUS is also gaining ground in peripheral vascular interventions for iliac, femoral, and renal artery disease management, especially as minimally invasive therapies expand in PAD (peripheral artery disease) treatment.

Additionally, both technologies are being increasingly integrated into research trials, teaching hospitals, and hybrid cath labs as part of advanced cardiovascular imaging protocols. Their use in emerging markets is also rising, driven by improved healthcare infrastructure and training programs in interventional cardiology and vascular surgery.

What Is Driving the Growth of the Global ICE and IVUS Market?
The growth in the global intracardiac echocardiography (ICE) and intravascular ultrasound (IVUS) market is driven by several factors, including the rising incidence of cardiovascular diseases, increasing adoption of minimally invasive interventions, and rapid advancements in catheter-based imaging technologies. The global surge in atrial fibrillation, coronary artery disease, and valvular disorders—combined with an aging population—is significantly expanding the patient pool for procedures that benefit from advanced intraluminal and intracardiac imaging.

The shift toward value-based healthcare and outcome-driven interventions is pushing hospitals and cardiology centers to adopt technologies that enhance procedural accuracy, reduce complications, and shorten recovery time. Technological convergence with 3D imaging, real-time guidance systems, and AI-based analytics is further elevating the clinical value of ICE and IVUS. Additionally, favorable reimbursement policies in North America and Europe, along with government initiatives supporting cardiac care infrastructure in Asia-Pacific and Latin America, are bolstering global adoption.

Rising demand for ambulatory and outpatient cardiac procedures, growing penetration of hybrid ORs, and expansion of EP and interventional training programs are also fueling market growth. With continuous innovation, increasing procedural volumes, and expanding clinical use cases, the ICE and IVUS markets are poised for strong and sustained growth in both developed and emerging economies.

SCOPE OF STUDY:

The report analyzes the Intracardiac Echocardiography and Intravascular Ultrasound market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Application (Electrophysiology Procedures, Left Atrial Appendage Closure, Septal Defects, Other Applications); End-Use (Hospitals, Catherization Laboratories, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

• Abbott Laboratories
• Acist Medical Systems
• Argon Medical Devices, Inc.
• Avinger Inc.
• B. Braun Melsungen AG
• BD (Becton, Dickinson and Company)
• Biomerics
• Boston Scientific Corporation
• Canon Medical Systems Corporation
• Chison Medical Technologies
• Conavi Medical
• Edwards Lifesciences
• Fujifilm Corporation
• GE Healthcare
• Hitachi Ltd.
• Infraredx Inc.
• Johnson & Johnson Services Inc.
• Medtronic plc
• MicroVention (Terumo)
• Mindray Medical International Ltd.
• Philips Healthcare
• Samsung Medison
• Shifamed LLC (NuVera Medical)
• Siemens Healthineers
• Spectranetics (a Philips company)
• Stereotaxis Inc.
• Stryker Corporation
• Terumo Corporation
• Vascular Solutions (Teleflex)
• Volcano Corporation (Philips)

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.